Clinical Trial: Colchicine for Acute Coronary Syndromes

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Colchicine for Acute Coronary Syndromes. A Multicenter Double Blind Randomized Trial.

Brief Summary: Multicenter, double blind, randomized trial to assess the effect of low-dose colchicine (0.5mg/day) on overall mortality, new coronary syndromes, and ischemic stroke at 2 years after an acute coronary syndrome. The study hypothesis is that colchicine may reduce the specified combined endpoint from 16% to 7-8% at a 2-years follow-up.